Zusammenfassung
Die häufigste Ursache eines Lymphödems der oberen Extremität ist die Behandlung eines Mammakarzinoms durch axillare Operation oder Bestrahlung. Die Inzidenz des Lymphödems korreliert dabei mit der Anzahl entfernter Lymphknoten, ist aber auch abhängig von patienten- und tumorassoziierten Eigenschaften. Durch die Sentinel-Lymphknoten-Entfernung, die heute bei klinisch nodal-negativen Patientinnen standardmäßig durchgeführt wird, ist es bereits zu einer deutlichen Reduktion von Lymphödemen des Armes gekommen. Anhand von klinischen Studien wird weiter untersucht, bei welchen Patientinnen auch bei Lymphknotenbefall schonender vorgegangen werden kann und wo auf eine Axilladissektion verzichtet werden kann. Bei bestehendem Lymphödem ist die frühzeitige Diagnose und Therapie entscheidend für die Lebensqualität der Patientin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Abu-Rustum NR, Gemignani ML, Moore K et al (2003) Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot-data and comparison to laparotomy. Gynecol Oncol 91:402–409
ASTEC study group, Kitchener H, Swart AM, Qian Q et al (2009) Efficacy of systemic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. The Lancet 373(9658): 125–136
Biglia N, Zanfagnini V, Daniele A et al (2017) Lower body lymphedema in patients with gynecologic cancer. Anticancer Res 37(8):4005–4015
Boileau JF, Poirier B, Basik M et al (2015) Sentinel node biopsy after eboadjuvant chemotherapy in biopsy-proven node-positive breast cancer: The SN FNAC Study. J Clin Oncol 33(3):258–264
Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310:1455–1461
Caudle A, Yang W, Krishnamurthy S et al (2016) Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol 34(10):1072–1078
Cibula D, Oonk MH, Abu-Rustum NR et al (2015) Sentinel lymph node biopsy in the management of gynecologic cancer. Curr Opin Obstet Gynecol 27(1):66–72
Classe JM, Campion L, Alran S et al (2014) Sentinel node surgery after neoadjuvant chemotherapy in patient with axillary node involvment: the French GANEA 2 prospective multi-institutional trial. San Antonio 2014 P2-01-01
Donker M, van Tienhoven G, Straver ME et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel in breast cancer (EORTC 10981-22023 AMAROS): a randomized, mulicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15(12):1303–1310
Frost JA, Webster KE, Bryant A et al (2015) Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev, September 21(9): CD007585
Galimberti V, Kahler Ribeiro Fontana S, Maisonneuve P et al (2016) Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Eur J Surg Oncol 42(3):361–368
Gartner R, Jensen MB, Kronborg L et al (2010) Self-reported arm-lymphedema and functional impairment after breast cancer treatment–a nationwide study of prevalence and associated factors. Breast 19:506–515
Garza III R, Skoracki R, Hock K (2017) A comprehensive overview of the surgical management od secondary lymphedema of the upper and lower extremeties related to prior oncologic therapies. BMC Cancer 17(1):468
Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575
Hayes S, Cornish B, Newman B (2005) Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat 89:221–226
Holloway RW, Abu-Rustum NR, Bakces FJ (2017) Sentinel lymph node mapping and staging in endometrial cancer: a society of gynecologic oncology literature review with consensus recommendations. Gynecol Oncol 146(2):405–415
Kuehn T, Bauerfeind I, Fehm T et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet 14:609–618
Lécuru F, Mathevet P, Querleu D et al (2011) Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol May1, 29(13): 1686–1691
Panici PB, Baile S, Maneschi F (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716
Panici PB, Maggioni A, Hacker N (2005) Systemic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97(8):560–566
Reimer T, Stachs A, Nekljudiva V (2017) Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c/iT1-2) in the context of breast conserving therapy: first results following commencement of the Intergroup-Sentinel-Mamma (INSEMA) trial. Geburtshilfe und Frauenheilkunde77(2): 149
Soliman PT et al (2017) A prospective validation study of sentinel lymph node mapping for high-risk endometrium cancer. Gynecol Oncol 146(2):234–239
Tanaka T, Terai Y, Fujiwara S et al (2017) Detection of sentinel lymph nodes in laaroscopic surgery can eliminate lymphadenectomy for patients with early stage endometrial cancer. Int J of Clin Oncol Nov. 2 https://doi.org/10.1007/s10147-017-1196-9
Wojcinski S, Nuengsri S, Hillemanns P et al (2012) Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity. Cancer Manag Res 4:121–127
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Fründt, S.L., Liedtke, C., Kühn, T., Untch, M. (2019). Lymphödem. In: Petru, E., Fink, D., Köchli, O., Loibl, S. (eds) Praxisbuch Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57430-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-662-57430-0_17
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57429-4
Online ISBN: 978-3-662-57430-0
eBook Packages: Medicine (German Language)